BSECorp. Action29 Aug 2026 · 29 Aug 2026, 03:05 pm
Pursuant to Regulation 42 of SEBI (LODR) Regulations, 2015, we would like to inform you that the 32nd Annual General Meeting of the Company is scheduled to be held on Wednesday, September ....
Lincoln Pharmaceuticals Ltd · 531633
✦ AI SummaryDividend
Lincoln Pharmaceuticals Ltd has announced the 32nd Annual General Meeting (AGM) scheduled for September 30, 2026, to determine the entitlement of members for payment of a final dividend of ₹ 1.80 per equity share, if approved.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Lincoln Pharmaceuticals Ltd - 531633 - Corporate Action-Fixes Book Closure For Determining The Dividend, If Approved At The AGM
Attachments (1)
📄pdf
Download →
dcd31b7b-cfa2-480d-bd43-11e80a8a7f47.pdf
View document text
LINCOLN
PHARMACEUTICALS LTD.
HEALTHCARE FOR ALL
Date: August 29, 2026
To To
The Manager, The Manager,
Listing Department, The Department of Corporate Service,
National Stock Exchange of India Limited, (NSE) BSE Limited, (BSE)
Exchange Plaza, C-1, Block-G, Bandra-Kurla Complex, Phiroze Jeejeebhoy Tower,
Bandra (E), Mumbai – 400 051. Dalal Street, Mumbai – 400 001.
Scrip Code – LINCOLN Scrip Code – 531633
Dear Sir / Madam,
Sub: Intimation of the Book Closure.
Pursuant to the Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like
to inform you that the 32nd Annual General Meeting of the Company is scheduled to be held on Wednesday, September
30, 2026 at 11:00 a.m. (IST) through Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM").
The details of the Book closure as per Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015 are as given below:
Particulars Details
Book Closure / Record Date Book Closure
Type of security Equity shares of Rs. 10/- each
Book Closure Start Date Saturday, September 12, 2026
Book Closure End Date Wednesday, September 30, 2026
For determining the entitlement of members for payment of Dividend if
Purpose
approved at the 32nd Annual General Meeting.
Dividend (%) 18%
Dividend Type Final Dividend: ₹ 1.80/- Per Equity Share of Face Value of ₹ 10/- each
Dividend for the Financial Year April 01, 2025 to March 31, 2026
Meeting (AGM) Date Wednesday, September 30, 2026
The Final Dividend is payable only when the same is approved by the members at the 32nd Annual General Meeting
We hope you will find the same in order and take the same on records.
Thanking you,
Yours faithfully,
For Lincoln Pharmaceuticals Limited
Trusha Shah
Company Secretary &
Compliance Officer
CC to:
1. National Securities Depository Limited
2. Central Depository Services (India) Limited
3. MUFG lntime India Private Limited
Regd. Office: "Lincoln House", Science City Road, Sola, Ahmedabad-380 060. Gujarat, India ����
Phone: +91-79-4107 8000 I Fax: +91-79-4107 8062 I CIN L24230GJ1995PLC024288
E-mail: info@lincolnpharma.com I Website : www.lincolnpharma.com
Factory: 10, 12, 13, Trimul Estate, Near Khatraj Chokadi, P.O. Khatraj-382721. lntertek 014
Ta.: Kalol, Dist. Gandhinagar, [Guj.] I Phone: +91-79-49135000 I E-mail: khatraj@lincolnpharma.com